Premium
Etanercept biosimilar SB 4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
Author(s) -
Gisondi P.,
Bianchi L.,
CalzavaraPinton P.,
Conti A.,
Chiricozzi A.,
Fimiani M.,
Pellegrino M.,
Giunta A.,
Prignano F.,
Tiberio R.,
Venturini M.,
Girolomoni G.
Publication year - 2019
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.17133
Subject(s) - biosimilar , etanercept , psoriasis , medicine , plaque psoriasis , dermatology , immunology , computational biology , pharmacology , tumor necrosis factor alpha , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom